|
| ID |
DDInter1701 |
| Drug Type |
small molecule |
| Molecular Formula |
C26H26F3N3O3 |
| Molecular Weight |
485.506
|
| Description |
Sonidegib is an antineoplastic agent used for the treatment of locally advanced recurrent basal cell carcinoma (BCC) following surgery and radiation therapy, or in cases where surgery or radiation therapy are not appropriate.
|
| ATC Classification |
L01XX48
|
| IUPAC Name |
N-{6-[(2R,6S)-2,6-Dimethylmorpholin-4-Yl]Pyridin-3-Yl}-2-Methyl-4'-(Trifluoromethoxy)-[1,1'-Biphenyl]-3-Carboxamide |
| InChI |
Inchi=1S/C26H26F3N3O3/C1-16-14-32(15-17(2)34-16)24-12-9-20(13-30-24)31-25(33)23-6-4-5-22(18(23)3)19-7-10-21(11-8-19)35-26(27,28)29/H4-13,16-17H,14-15H2,1-3H3,(H,31,33)/T16-,17+ |
| InChI Key |
VZZJRYRQSPEMTK-CALCHBBNSA-N |
| Canonical SMILES |
[H][C@]1(C)CN(C[C@@]([H])(C)O1)C1=CC=C(NC(=O)C2=CC=CC(=C2C)C2=CC=C(OC(F)(F)F)C=C2)C=N1 |
| Useful Links |
DrugBank
ChEMBL
PubChem
|